Anchorage Capital Group, L.L.C.

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Anchorage Capital Group, L.L.C. reported 5 stock positions worth $374.8 million. Its top holding was Frontier Communications Pare (FYBR) at 48.6% of the portfolio, followed by Sentinelone Class A (S, 31.5%) and Roivant Sciences (ROIV, 14.9%). Its holdings were unchanged from Q2 2024.

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001300714
Portfolio Value
$374.8M (Q3 2024)
SEC Filing
0000905148-24-003149 ↗ filed Nov 14, 2024

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $377.5M Q1 2024 Q2 2024: $316.7M Q2 2024 Q3 2024: $374.8M $374.8M Q3 2024 Q4 2024: $272.5M Q4 2024 Q1 2025: $239.9M Q1 2025 Q2 2025: $258.7M Q2 2025 Q3 2025: $117.4M Q3 2025 Q4 2025: $88.6M Q4 2025 Q1 2026: $436.3M Q1 2026 Q2 2026: $450.5M Q2 2026

Holdings 5 stocks · $374.8M
FYBR Frontier Communications Pare 48.56% 5,123,545 $182.0M No change
S Sentinelone Inc. Class A 31.50% 4,937,053 $118.1M No change
ROIV Roivant Sciences Ltd. 14.88% 4,832,642 $55.8M No change
DNA Ginkgo Bioworks Holdings Inc. 3.80% 1,746,363 $14.2M No change
AMBP Ardagh Metal Packaging SA 1.26% 1,250,000 $4.7M No change
Other holdings (2): bonds, preferreds, convertibles and warrants · $7.1M (not counted above)
SecurityClassShares / PrincipalValueChange
THE REALREAL INC (REAL 1 03/01/28) NOTE 1.000% 3/0 · principal 15,097,000$7.1MNo change
AMPWF Ardagh Metal Packaging -CW26 *W EXP 08/04/202 1,245,385$52KNo change

Total filed on the 13F, all lines: $382.0M.

Portfolio Sells Q2 2024 → Q3 2024
None this quarter.

Portfolio Buys Q2 2024 → Q3 2024
None this quarter.

Notes & Other Activity Q2 2024 → Q3 2024
DNABW Ginkgo Bioworks -CW27 *W EXP 09/16/202 Sold out 50,000 $1Kbefore exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$450.5MEQPT, S, DNA
Q1 2026 3$436.3MEQPT, S, DNA
Q4 2025 2$88.6MS, DNA
Q3 2025 3$117.4MS, DNA, AMBP
Q2 2025 5$258.7MS, FYBR, ROIV, DNA, AMBP
Q1 2025 5$239.9MS, FYBR, ROIV, DNA, AMBP
Q4 2024 5$272.5MS, FYBR, ROIV, DNA, AMBP
Q3 2024 5$374.8MFYBR, S, ROIV, DNA, AMBP
Q2 2024 5$316.7MFYBR, S, ROIV, DNA, AMBP
Q1 2024 6$377.5MFYBR, S, DNA, ROIV, AMBP